Skip to content

The correct selection of Cognitive Impairment scale and the correlation between serum neuron specific enolase level and Cognitive Impairment

The correct selection of Cognitive Impairment scale and the correlation between NSE level and Cognitive Impairment in patients with Diabetic Retinopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015758
Enrollment
Unknown
Registered
2018-04-18
Start date
2018-04-18
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment

Interventions

patients with diabetic retinopathy:Nil
patients without diabetic retinopathy:Nil

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: A total of 280 hospitalized patients in our hospital were selected. The number of 140 patients with diabetic retinopathy were diagnosed by fundus ophthalmoscope and fluorescein sodium fundus angiography, and 140 patients were not with diabetic retinopathy.

Exclusion criteria

Exclusion criteria: There are other major diseases such as autoimmune diseases, acute infectious diseases, acute diabetic complications, primary renal diseases, kidney stones, other major diseases such as primary or secondary fundus. Patients who had intervened in cognitive functional drugs; patients with previous cerebral apoplexy or hemorrhagic stroke; psychotic disorders requiring long-term medication for mental state intervention; patients with abnormal liver and kidney metabolic abnormalities; perennial alcoholism and abuse of toxic hemp drugs; low educational level, Patients who do not have basic cognitive ability (Wen Mang).

Design outcomes

Primary

MeasureTime frame
neuron specific enolase;

Countries

China

Contacts

Public ContactXinyuan Gao

The First Affiliated Hospital of Harbin Medical University

15369337970@163.com+86 13904517001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026